Tongmei Zhang

机构：Capital Medical University, Beijing Chest Hospital · ORCID：0000-0003-4271-3773

发表论文 90 篇 · 总被引 736 次 · h-index 14

代表论文

• Liquid biopsy using plasma proteomics in predicting efficacy and tolerance of PD-1/PD-L1 blockades in NSCLC: a prospective exploratory study (2025 · Molecular Biomedicine · 被引 14)
• A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer (2025 · Signal Transduction and Targeted Therapy · 被引 10)
• A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer. (2025 · Journal of Clinical Oncology · 被引 6)
• Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies (2025 · Therapeutic Advances in Medical Oncology · 被引 6)
• Clinical and imaging features of co-existent pulmonary tuberculosis and lung cancer: a population-based matching study in China (2025 · BMC Cancer · 被引 5)
• Abstract CT053: Aumolertinib with or without chemotherapy as first line treatment in locally advanced or metastatic NSCLC with sensitizing EGFR mutations (AENEAS2) (2025 · Cancer Research · 被引 4)